Search in:

Leukemia & Lymphoma Volume 60, 2019 - Issue 2

Submit an article Journal homepage

Open access

2,441

Views

CrossRef citations to date

Altmetric

Original Article: Research

Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation

Amelie Kincha Department of Medical Sciences, Section of Infectious Diseases, Uppsala University, Uppsala, Sweden; Correspondence[email protected]

https://orcid.org/0000-0003-3420-8590

Christer Sundströmb Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden;

Eva Baecklundc Department of Medical Sciences, Section of Rheumatology, Uppsala University, Uppsala, Sweden;

Carin Backlinc Department of Medical Sciences, Section of Rheumatology, Uppsala University, Uppsala, Sweden; ;d Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden;

Daniel Moline Experimental and Clinical Oncology, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden

Gunilla Enblade Experimental and Clinical Oncology, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden

https://orcid.org/0000-0002-0594-724X

Pages 376-384 | Received 12 Jan 2018, Accepted 07 May 2018, Published online: 22 Jul 2018

Cite this article
https://doi.org/10.1080/10428194.2018.1480767
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (26)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (26)

Ashley V. Geerlinks, Upton Allen, Bo‐Yee Ngan & Angela Punnett. (2023) PD‐L1 and PD‐1 expression in pediatric post‐transplant Burkitt lymphoma and other monomorphic post‐transplant lymphoproliferative disorders. Pediatric Blood & Cancer 70:12.
Crossref

Thomas G. Gross & Jeremy D. Rubinstein. (2023) Post‐transplant lymphoproliferative disease in children, adolescents, and young adults. Hematological Oncology 41:S1, pages 48-56.
Crossref

Suheil Albert Atallah‐Yunes, Omar Salman & Michael J. Robertson. (2023) Post‐transplant lymphoproliferative disorder: Update on treatment and novel therapies. British Journal of Haematology 201:3, pages 383-395.
Crossref

Jeremy Rubinstein, Keri Toner, Thomas Gross & Birte Wistinghausen. (2023) Diagnosis and management of post-transplant lymphoproliferative disease following solid organ transplantation in children, adolescents, and young adults. Best Practice & Research Clinical Haematology 36:1, pages 101446.
Crossref

Michele Clerico, Irene Dogliotti, Andrea Aroldi, Chiara Consoli, Luisa Giaccone, Benedetto Bruno & Federica Cavallo. (2022) Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options. Journal of Clinical Medicine 11:24, pages 7542.
Crossref

Ayako Kume, Aya Shinozaki-Ushiku, Akiko Kunita, Atsushi Kondo & Tetsuo Ushiku. (2022) Enhanced PD-L1 Expression in LMP1-positive Cells of Epstein-Barr Virus–associated Malignant Lymphomas and Lymphoproliferative Disorders. American Journal of Surgical Pathology 46:10, pages 1386-1396.
Crossref

Daan Dierickx, Martyna Pociupany & Yaso Natkunam. (2022) Epstein-Barr virus-associated posttransplant lymphoproliferative disorders: new insights in pathogenesis, classification and treatment. Current Opinion in Oncology 34:5, pages 413-421.
Crossref

Keri Toner & Catherine M. Bollard. (2022) EBV+ lymphoproliferative diseases: opportunities for leveraging EBV as a therapeutic target. Blood 139:7, pages 983-994.
Crossref

Kevin E. Fisher, Lizmery S. Ferguson, Amy M. Coffey, Brian Y. Merritt, Jonathan L. Curry, Andrea N. Marcogliese, Angela M. Major, Kala Y. Kamdar, Dolores H. Lopez-Terrada & Choladda V. Curry. (2022) Programmed cell death ligand 1 expression in aggressive pediatric non-Hodgkin lymphomas: frequency, genetic mechanisms, and clinical significance. Haematologica 107:8, pages 1880-1890.
Crossref

Akihiro Ohmoto & Shigeo Fuji. (2021) Clinical features and treatment strategies for post-transplant and iatrogenic immunodeficiency-associated lymphoproliferative disorders. Blood Reviews 49, pages 100807.
Crossref

Ben Sprangers, Leonardo V. Riella & Daan Dierickx. (2021) Posttransplant Lymphoproliferative Disorder Following Kidney Transplantation: A Review. American Journal of Kidney Diseases 78:2, pages 272-281.
Crossref

L. B. Krougly, N. N. Koloskova, A. V. Nikulin, I. V. Pashkov, V. N. Poptsov & A. O. Shevchenko. (2021) Сlinical features of malignant tumors against the background of immunosuppressive therapy in heart transplant recipients. Russian Journal of Transplantology and Artificial Organs 23:2, pages 167-176.
Crossref

Mauro García Montenegro, Marina Narbaitz, María Fernanda Metrebian, Astrid Pavlovsky & Irma Slavutsky. (2021) Desbalances genómicos del locus 9p24.1 en pacientes argentinos con linfoma de Hodgkin clásico. Revista Médicas UIS 34:1.
Crossref

Mathis Overkamp, Massimo Granai, Irina Bonzheim, Julia Steinhilber, Jens Schittenhelm, Wolfgang Bethge, Leticia Quintanilla-Martinez, Falko Fend & Birgit Federmann. (2020) Comparative analysis of post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation reveals differences in the tumor microenvironment. Virchows Archiv 478:6, pages 1135-1148.
Crossref

Yusuke Yanagi, Yusuke Okuno, Yohei Narita, H.M. Abdullah Al Masud, Takahiro Watanabe, Yoshitaka Sato, Teru Kanda, Hiroshi Kimura & Takayuki Murata. (2021) RNAseq analysis identifies involvement of EBNA2 in PD-L1 induction during Epstein-Barr virus infection of primary B cells. Virology 557, pages 44-54.
Crossref

Cecilia Nakid-Cordero, Marine Baron, Amélie Guihot & Vincent Vieillard. (2021) Natural Killer Cells in Post-Transplant Lymphoproliferative Disorders. Cancers 13:8, pages 1836.
Crossref

Maansi Joshi & Stephen M. Ansell. (2020) Activating the Antitumor Immune Response in Non-Hodgkin Lymphoma Using Immune Checkpoint Inhibitors. Journal of Immunology Research 2020, pages 1-12.
Crossref

Mizuki Watanabe, Junya Kanda, Masakatsu Hishizawa, Momoko Nishikori, Tadakazu Kondo, Kouhei Yamashita & Akifumi Takaori-Kondo. (2020) Lymphopenia at diagnosis predicts survival of patients with immunodeficiency-associated lymphoproliferative disorders. Annals of Hematology 99:7, pages 1565-1573.
Crossref

Valeria Ferla, Francesca Gaia Rossi, Maria Cecilia Goldaniga & Luca Baldini. (2020) Biological Difference Between Epstein–Barr Virus Positive and Negative Post-transplant Lymphoproliferative Disorders and Their Clinical Impact. Frontiers in Oncology 10.
Crossref

Reid W. Merryman, Roch Houot, Philippe Armand & Caron Jacobson. (2020) Immune and Cell Therapy in Non-Hodgkin Lymphoma. The Cancer Journal 26:3, pages 269-277.
Crossref

Upton D. Allen & Jutta K. Preiksaitis. (2019) Post‐transplant lymphoproliferative disorders, Epstein‐Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clinical Transplantation 33:9.
Crossref

Ana‐Iris Schiefer, Elisabeth Salzer, Anna Füreder, Zsolt Szepfalusi, Thomas Müller‐Sacherer, Wolf‐Dietrich Huber, Ina Michel‐Behnke, Anita Lawitschka, Herbert Pichler, Georg Mann, Caroline Hutter, Ingrid Simonitsch‐Klupp & Andishe Attarbaschi. (2019) PD‐L1 and PD1 expression in post‐transplantation lymphoproliferative disease (PTLD) of childhood and adolescence: An inter‐ and intra‐individual descriptive study covering the whole spectrum of PTLD categories. Cancer Medicine 8:10, pages 4656-4668.
Crossref

Lukas Marcelis & Thomas Tousseyn. (2019) The Tumor Microenvironment in Post-Transplant Lymphoproliferative Disorders. Cancer Microenvironment 12:1, pages 3-16.
Crossref

Jennifer L. Crombie & Ann S. LaCasce. (2019) Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders. Frontiers in Oncology 9.
Crossref

Stefan D. Dojcinov & Matthew R. Pugh. (2019) The pathology of epstein-barr virus lymphoproliferations. HemaSphere 3, pages 70-73.
Crossref

Daan Dierickx & Vibeke Vergote. (2019) Management of post-transplant lymphoproliferative disorders. HemaSphere 3, pages 74-77.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation

Articles from other publishers (26)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation

Citations (26)

Articles from other publishers (26)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date